カテゴリー： QYResearch, 世界, 医療/バイオ

アカルボース医薬品のグローバル市場2023年：錠剤、カプセル

◆英語タイトル：Global Acarbose Drug Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8651）◆商品コード：QYR23MA8651
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：68
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のアカルボース医薬品市場について調査・分析し、世界のアカルボース医薬品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（錠剤、カプセル）、用途別セグメント分析（病院、薬局、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Bayer、Huadong Medicine、Beijing Winsunny、Luye Pharma Groupなどが含まれています。世界のアカルボース医薬品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、アカルボース医薬品市場規模を推定する際に考慮しました。

・アカルボース医薬品市場の概要
- 製品の定義
- アカルボース医薬品のタイプ別セグメント
- 世界のアカルボース医薬品市場規模：タイプ別分析（錠剤、カプセル）
- アカルボース医薬品の用途別セグメント
- 世界のアカルボース医薬品市場規模：用途別分析（病院、薬局、その他）
- 世界のアカルボース医薬品市場規模予測（2018年-2029年）
- アカルボース医薬品の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- アカルボース医薬品市場の競争状況およびトレンド

・アカルボース医薬品の地域別市場規模
- 北米のアカルボース医薬品市場規模（2018年-2029年）
- アメリカのアカルボース医薬品市場規模（2018年-2029年）
- ヨーロッパのアカルボース医薬品市場規模（2018年-2029年）
- アジア太平洋のアカルボース医薬品市場規模（2018年-2029年）
- 中国のアカルボース医薬品市場規模（2018年-2029年）
- 日本のアカルボース医薬品市場規模（2018年-2029年）
- 韓国のアカルボース医薬品市場規模（2018年-2029年）
- インドのアカルボース医薬品市場規模（2018年-2029年）
- オーストラリアのアカルボース医薬品市場規模（2018年-2029年）
- 中南米のアカルボース医薬品市場規模（2018年-2029年）
- 中東・アフリカのアカルボース医薬品市場規模（2018年-2029年）

・タイプ別セグメント：錠剤、カプセル
- 世界のアカルボース医薬品のタイプ別販売量（2018年-2023年）
- 世界のアカルボース医薬品のタイプ別売上（2018年-2023年）
- 世界のアカルボース医薬品のタイプ別価格

・用途別セグメント：病院、薬局、その他
- 世界のアカルボース医薬品の用途別販売量（2018年-2023年）
- 世界のアカルボース医薬品の用途別売上（2018年-2023年）
- 世界のアカルボース医薬品の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Bayer、Huadong Medicine、Beijing Winsunny、Luye Pharma Group

・産業チェーンと販売チャネルの分析
- アカルボース医薬品産業チェーン分析
- アカルボース医薬品の主要原材料
- アカルボース医薬品の販売チャネル
- アカルボース医薬品のディストリビューター
- アカルボース医薬品の主要顧客

・アカルボース医薬品市場ダイナミクス
- アカルボース医薬品の業界動向
- アカルボース医薬品市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Acarbose Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Acarbose Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Acarbose Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Acarbose Drug include Bayer, Huadong Medicine, Beijing Winsunny and Luye Pharma Group, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Acarbose Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acarbose Drug.
The Acarbose Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acarbose Drug market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acarbose Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bayer
Huadong Medicine
Beijing Winsunny
Luye Pharma Group
Segment by Type
Tablets
Capsules
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acarbose Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acarbose Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Acarbose Drug Market Overview
1.1 Product Overview and Scope of Acarbose Drug
1.2 Acarbose Drug Segment by Type
1.2.1 Global Acarbose Drug Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Capsules
1.3 Acarbose Drug Segment by Application
1.3.1 Global Acarbose Drug Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Acarbose Drug Market Size Estimates and Forecasts
1.4.1 Global Acarbose Drug Revenue 2018-2029
1.4.2 Global Acarbose Drug Sales 2018-2029
1.4.3 Global Acarbose Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Acarbose Drug Market Competition by Manufacturers
2.1 Global Acarbose Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Acarbose Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Acarbose Drug Average Price by Manufacturers (2018-2023)
2.4 Global Acarbose Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Acarbose Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acarbose Drug, Product Type & Application
2.7 Acarbose Drug Market Competitive Situation and Trends
2.7.1 Acarbose Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acarbose Drug Players Market Share by Revenue
2.7.3 Global Acarbose Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acarbose Drug Retrospective Market Scenario by Region
3.1 Global Acarbose Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Acarbose Drug Global Acarbose Drug Sales by Region: 2018-2029
3.2.1 Global Acarbose Drug Sales by Region: 2018-2023
3.2.2 Global Acarbose Drug Sales by Region: 2024-2029
3.3 Global Acarbose Drug Global Acarbose Drug Revenue by Region: 2018-2029
3.3.1 Global Acarbose Drug Revenue by Region: 2018-2023
3.3.2 Global Acarbose Drug Revenue by Region: 2024-2029
3.4 North America Acarbose Drug Market Facts & Figures by Country
3.4.1 North America Acarbose Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Acarbose Drug Sales by Country (2018-2029)
3.4.3 North America Acarbose Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Acarbose Drug Market Facts & Figures by Country
3.5.1 Europe Acarbose Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Acarbose Drug Sales by Country (2018-2029)
3.5.3 Europe Acarbose Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acarbose Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Acarbose Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Acarbose Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Acarbose Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Acarbose Drug Market Facts & Figures by Country
3.7.1 Latin America Acarbose Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Acarbose Drug Sales by Country (2018-2029)
3.7.3 Latin America Acarbose Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acarbose Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Acarbose Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Acarbose Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Acarbose Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acarbose Drug Sales by Type (2018-2029)
4.1.1 Global Acarbose Drug Sales by Type (2018-2023)
4.1.2 Global Acarbose Drug Sales by Type (2024-2029)
4.1.3 Global Acarbose Drug Sales Market Share by Type (2018-2029)
4.2 Global Acarbose Drug Revenue by Type (2018-2029)
4.2.1 Global Acarbose Drug Revenue by Type (2018-2023)
4.2.2 Global Acarbose Drug Revenue by Type (2024-2029)
4.2.3 Global Acarbose Drug Revenue Market Share by Type (2018-2029)
4.3 Global Acarbose Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Acarbose Drug Sales by Application (2018-2029)
5.1.1 Global Acarbose Drug Sales by Application (2018-2023)
5.1.2 Global Acarbose Drug Sales by Application (2024-2029)
5.1.3 Global Acarbose Drug Sales Market Share by Application (2018-2029)
5.2 Global Acarbose Drug Revenue by Application (2018-2029)
5.2.1 Global Acarbose Drug Revenue by Application (2018-2023)
5.2.2 Global Acarbose Drug Revenue by Application (2024-2029)
5.2.3 Global Acarbose Drug Revenue Market Share by Application (2018-2029)
5.3 Global Acarbose Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Acarbose Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer Acarbose Drug Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Huadong Medicine
6.2.1 Huadong Medicine Corporation Information
6.2.2 Huadong Medicine Description and Business Overview
6.2.3 Huadong Medicine Acarbose Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Huadong Medicine Acarbose Drug Product Portfolio
6.2.5 Huadong Medicine Recent Developments/Updates
6.3 Beijing Winsunny
6.3.1 Beijing Winsunny Corporation Information
6.3.2 Beijing Winsunny Description and Business Overview
6.3.3 Beijing Winsunny Acarbose Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Beijing Winsunny Acarbose Drug Product Portfolio
6.3.5 Beijing Winsunny Recent Developments/Updates
6.4 Luye Pharma Group
6.4.1 Luye Pharma Group Corporation Information
6.4.2 Luye Pharma Group Description and Business Overview
6.4.3 Luye Pharma Group Acarbose Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Luye Pharma Group Acarbose Drug Product Portfolio
6.4.5 Luye Pharma Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acarbose Drug Industry Chain Analysis
7.2 Acarbose Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acarbose Drug Production Mode & Process
7.4 Acarbose Drug Sales and Marketing
7.4.1 Acarbose Drug Sales Channels
7.4.2 Acarbose Drug Distributors
7.5 Acarbose Drug Customers
8 Acarbose Drug Market Dynamics
8.1 Acarbose Drug Industry Trends
8.2 Acarbose Drug Market Drivers
8.3 Acarbose Drug Market Challenges
8.4 Acarbose Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ アカルボース医薬品のグローバル市場2023年：錠剤、カプセル(Global Acarbose Drug Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 慢性痛風治療薬のグローバル市場展望 2023年-2029年：錠剤、カプセル、その他
  • アカルボース医薬品の世界市場見通し2023年-2029年
  • 世界の経口用新型コロナウイルス感染症治療剤市場インサイト及び予測（錠剤、カプセル）
  • 世界のアセブロフィリン薬市場インサイト及び予測（錠剤、シロップ、内用液、カプセル、その他）
  • 世界のアカルボースAPI市場2022年：微生物発酵法、化学合成法